Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riken Vitamin CoTSE:4526 -0.30%78 Debt-to-EBITDA is 0.28 as of Mar. 2026, which is 76% below its 10-year median of 1.15. GuruFocus rates TSE:4526 with a GF Score™ of 78/100 and a GF Value™ of 円2,869.71 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,559 Consumer Packaged Goods companies, Riken Vitamin Co ranks better than 79.15% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Riken Vitamin Co's Debt-to-EBITDA or its related term are showing as below:
TSE:4526'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -10.62 Med: 1.15 Max: 5.28
Current: 0.49
During the past 13 years, the highest Debt-to-EBITDA Ratio of Riken Vitamin Co was 5.28. The lowest was -10.62. And the median was 1.15.
TSE:4526's Debt-to-EBITDA is ranked better than 79.15% of 1559
companies
in the Consumer Packaged Goods industry
Industry Median: 2.12
vs TSE:4526: 0.49
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Riken Vitamin Co Debt-to-EBITDA Related Terms
Riken Vitamin Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Riken Vitamin Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Riken Vitamin Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riken Vitamin Co Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Riken Vitamin Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Riken Vitamin Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Riken Vitamin Co (TSE:4526) has a Debt-to-EBITDA of 0.28 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Riken Vitamin Co. This is 76% below median its historical median of 1.15. According to the industry distribution chart, Riken Vitamin Co ranks #325 out of 1559 companies in the Consumer Packaged Goods industry, placing it in the top 20.8%.
Is Riken Vitamin Co's Debt-to-EBITDA too high?
Riken Vitamin Co's current Debt-to-EBITDA of 0.28 is 76% below median its 10-year median of 1.15. The Consumer Packaged Goods industry median Debt-to-EBITDA is 2.12. Riken Vitamin Co's value of 0.28 is 86.8% below this industry median. Based on the distribution chart, Riken Vitamin Co ranks #325 out of 1559 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Riken Vitamin Co has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Riken Vitamin Co's Debt-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Riken Vitamin Co ranks #325 out of 1559 companies for Debt-to-EBITDA. This places Riken Vitamin Co in the top 21% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.12. Riken Vitamin Co's value of 0.28 is 86.8% below this benchmark. While the company's 10-year median is 1.15 vs. the industry median of 2.12, Riken Vitamin Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.12, based on 1,559 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riken Vitamin Co's current Debt-to-EBITDA of 0.28 is 86.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Riken Vitamin Co. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riken Vitamin Co's current Debt-to-EBITDA is 0.28, which is 76% below median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riken Vitamin Co stock overvalued right now?
Based on GuruFocus' analysis, Riken Vitamin Co (TSE:4526) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,869.71, compared to a current price of 円3,330.00 — trading 16% above its estimated fair value. The current Debt-to-EBITDA is 0.28, which is 76% below median its 10-year median of 1.15 and 86.8% below the Consumer Packaged Goods industry median of 2.12. Riken Vitamin Co's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Riken Vitamin Co (TSE:4526), the current Debt-to-EBITDA is 0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riken Vitamin Co (TSE:4526) Overvalued in 2026?
Based on GuruFocus' analysis, Riken Vitamin Co stock appears to be overvalued.
The current stock price of 円3,330.00 is trading 16% above its estimated GF Value™ of 円2,869.71.
GuruFocus considers Riken Vitamin Co to be Modestly Overvalued.
Key valuation signals for TSE:4526:
Debt-to-EBITDA: 0.28 (76% below median its 10-year median of 1.15)
GF Value™: 円2,869.71 vs. price of 円3,330.00 (16% above fair value)
Industry Position: 86.8% below the Consumer Packaged Goods median (#325 of 1559)
No single metric tells the full story. See the TSE:4526 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riken Vitamin Co Ltd is a Japan based animal food manufacturing company. It is a developer and producer of a wide variety of improvers that is broadly used to improve the texture and quality of processed food. It is engaged in consumer and commercial foods, processed food ingredients, food chemicals for industrial uses and Vitamin production and sales. The company's food emulsifiers are used in various applications such as cakes, bread, noodles, ice cream, as well as fat and oil food product. In addition to emulsifiers, Riken Vitamin also provides a range of other food improvers for various purposes according to relevant consumer needs.
78GF Score
Get the complete analysis for TSE:4526
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4526 has been successfully added to your 
